Clinical trial

Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia

NCT03576885

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-07-15

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2019-07-15Date precision: day

Registry last updated2025-01-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Hypertensionunresolved

Bronchopulmonary Dysplasiaunresolved

Interventions

inhaled nitric oxideDRUG

PlaceboDRUG

Sponsors & collaborators

AdventHealthlead sponsor

Mallinckrodtcollaborator

Thrasher Research Fundcollaborator

Mapped research locations

OrlandoFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03576885 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.